Inflammation in Renal Disease
- 5 December 2005
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 97 (2), 20-27
- https://doi.org/10.1016/j.amjcard.2005.11.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) studyJournal of Clinical Pathology, 2004
- Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk ScoresCirculation, 2004
- Rosuvastatin-Induced Arrest in Progression of Renal DiseaseJMIR AI, 2004
- C-Reactive Protein and the Risk of Developing HypertensionJAMA, 2003
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAmerican Journal of Kidney Diseases, 2003
- C-reactive protein is associated with renal function abnormalities in a non-diabetic populationKidney International, 2003
- Inflammation and cardiovascular risk in dialysis patientsKidney International, 2002
- Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System InhibitionAnnals of Internal Medicine, 2002
- End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?Kidney International, 2001
- Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)The American Journal of Cardiology, 1999